Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Small Cajal body-specific RNA 6 (SCARNA6)** is a non-coding RNA molecule found in the Cajal bodies of the nucleus where it is involved in the modification of small nuclear RNAs (snRNAs). SCARNA6 is classified as a small Cajal body-specific RNA (scaRNA)—a class of RNA guides that localize to Cajal bodies and participate in the biochemical modification (such as pseudouridylation or 2'-O-methylation) of other small RNAs involved in RNA processing and splicing. As a non-protein-coding RNA, it does not fulfill typical criteria for being a direct drug target such as receptors or enzymes, and it has no established role as a disease biomarker or druggable site[5]. The gene symbol **ENSG00000252798** does not represent a protein-coding gene, and therefore most typical target-related fields (interacting drugs, mechanism of action, biomarker relevance, or clinical safety) are not applicable. If your intention was to inquire about a druggable protein, this target does not fit the conventional categories or use-cases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Cajal body-specific RNA 6 (SCARNA6).